Volume 3 of the widely cited report adds significant new content to the first two volumes, which established an industry-consensus approach to measuring clinical and financial outcomes in programs to prevent and manage chronic conditions.
"DMAA continues to build strong consensus among all stakeholders around our Guidelines, and this latest work honors that commitment to inclusiveness and transparency,"
The Volume 3 Outcomes Guidelines Report complements the earlier works and expands and refines measurement approaches in multiple areas, including:
* Validation of identification methodology recommendations.
* Measures of medication adherence.
* Expanded guidelines for evaluating wellness programs.
* Definitions of the operational process of delivering a program.
* Guiding principles for evaluating programs for more than one condition.
Donald Fetterolf, MD, executive vice president, health intelligence, Alere, and co-chair of the DMAA Outcomes Steering Committee with independent consultant and DMAA Board member Sue Jennings, PhD, said the new volume, like its predecessors, balances scientific rigor with practicality. "That continues as an overarching theme of this process," he said. "Ultimately, our goal of improving care depends on real-world application of these guidelines."
Jennings emphasized that DMAA did not design the Guidelines as a "plug-and-play"
DMAA released its first Outcomes Guidelines Report in December 2006 and a second volume in September 2007. Contributors to the development process include notable quality improvement organizations, such as the National Committee for Quality Assurance, URAC and The Joint Commission. Scores of industry experts, actuaries and leaders in government also provided comment.
All three volumes of the guidelines and other important DMAA research documents are available at www.dmaa.org.
Reporters & Editors, note: PDF copies of Volume 3 are available upon request to qualified media.
# # #
About DMAA: The Care Continuum Alliance
DMAA: The Care Continuum Alliance convenes all stakeholders providing services along the continuum of care for population health improvement, including health and wellness promotion, disease management and care coordination. Through advocacy, research and promotion of best practices, DMAA advances population-based strategies to improve care quality and outcomes and reduce preventable costs for individuals with and at risk of chronic conditions. DMAA represents more than 200 corporate and individual stakeholders, including wellness, disease and care management organizations, pharmaceutical manufacturers and benefit managers, health information technology innovators, biotechnology innovators, employers, physicians, nurses and other health care professionals, and researchers and academicians. Learn more at www.dmaa.org.